Neuberger Berman Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $353K | Buy |
|
|||||
2024
Q4 | $525K | Sell |
|
|||||
2024
Q3 | $15.1M | Buy |
|
|||||
2024
Q2 | $14M | Buy |
|
|||||
2024
Q1 | $11.1M | Buy |
|
|||||
2023
Q4 | $6.76M | Sell |
|
|||||
2023
Q3 | $8.63M | Sell |
|
|||||
2023
Q2 | $8.16M | Buy |
|
|||||
2023
Q1 | $9.82M | Buy |
|
|||||
2022
Q4 | $549K | Sell |
|
|||||
2022
Q3 | $470K | Buy |
|
|||||
2022
Q2 | $311K | Buy |
|
|||||
2022
Q1 | $222K | Buy |
|
|||||
2021
Q1 | – | Sell |
|
|||||
2020
Q4 | $6.42M | Buy |
|
|||||
2019
Q3 | – | Sell |
|
|||||
2019
Q2 | $9.35M | Buy |
|
|||||
2019
Q1 | $7.15M | Sell |
|
|||||
2018
Q4 | $6.77M | Sell |
|
|||||
2018
Q3 | $21.2M | Sell |
|
|||||
2018
Q2 | $17.5M | Buy |
|
|||||
2018
Q1 | $1.86M | Buy |
|
|||||
2017
Q4 | $989K | Sell |
|
|||||
2017
Q3 | $1.13M | Buy |
|